Evidence map›Paper›PMID 28700738›Full record

ArticlePloS one2017

Age dependent differences in the kinetics of γδ T cells after influenza vaccination.

Ulrik Stervbo, Dominika Pohlmann, Udo Baron, Cecilia Bozzetti, Karsten Jürchott, Julia Nora Mälzer, Mikalai Nienen, Sven Olek, Toralf Roch, Axel Ronald Schulz and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. [Choice of influenza vaccine in people over 65 years old. Analysis of reports from international vaccination advisory committees].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Article
  3. Review
  4. [Influenza].Der Internist · 2021
    Review
  5. Article
  6. Review
  7. A Cell for the Ages: Human γδ T Cells across the Lifespan.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Protective Role ofJournal of immunology research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Ulrik StervboBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.ORCID http://orcid.org/0000-0002-2831-8868
Dominika PohlmannBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Udo BaronEpiontis GmbH, Rudower Chaussee 29, Berlin, Germany.
Cecilia BozzettiBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Karsten JürchottBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Julia Nora MälzerBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Mikalai NienenCenter for Translational Medicine, Medical Clinic I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Hölkeskampring 40, Herne, Germany.
Sven OlekEpiontis GmbH, Rudower Chaussee 29, Berlin, Germany.
Toralf RochInstitute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Centre for Materials and Coastal Research, Kantstraße 55, Teltow, Germany.
Axel Ronald SchulzBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Sarah WarthBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Avidan NeumannBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Andreas ThielBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Andreas GrützkauDeutsches Rheuma-Forschungszentrum Berlin-a Leibniz Institute, Charitéplatz 1, Berlin, Germany.
Nina BabelBerlin-Brandenburg Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.
Berlin-Brandenburger Centrum für Regenerative Therapien · DEUniversitätsklinik Marien Hospital Herne · DEGerman Rheumatism Research Centre · DEHelmholtz-Zentrum Hereon · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosenescence is a hallmark of the aging immune system and is considered the main cause of a reduced vaccine efficacy in the elderly. Although γδ T cells can become activated by recombinant influenza hemagglutinin, their age-related immunocompetence during a virus-induced immune response has so far not been investigated. In this study we evaluate the kinetics of γδ T cells after vaccination with the trivalent 2011/2012 northern hemisphere seasonal influenza vaccine. We applied multi-parametric flow cytometry to a cohort of 21 young (19-30 years) and 23 elderly (53-67 years) healthy individuals. Activated and proliferating γδ T cells, as identified by CD38 and Ki67 expression, were quantified on the days 0, 3, 7, 10, 14, 17, and 21. We observed a significantly lower number of activated and proliferating γδ T cells at baseline and following vaccination in elderly as compared to young individuals. The kinetics changes of activated γδ T cells were much stronger in the young, while corresponding changes in the elderly occurred slower. In addition, we observed an association between day 21 HAI titers of influenza A and the frequencies of Ki67+ γδ T cells at day 7 in the young. In conclusion, aging induces alterations of the γδ T cell response that might have negative implications for vaccination efficacy.

Indexed as

ADP-ribosyl Cyclase 1AdultAgedAgingFemaleHumansInfluenza, HumanInfluenza VaccinesKi-67 AntigenKineticsMaleMiddle AgedT-LymphocytesYoung AdultADP-ribosyl Cyclase 1Influenza VaccinesKi-67 Antigen

Identifiers

PMID28700738
PMCPMC5507438
OpenAlexW2734388245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.